|
1
|
Deschler B and Lübbert M: Acute myeloid
leukemia: Epidemiology and etiology. Cancer. 107:2099–2107.
2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang ZY and Chen Z: Acute promyelocytic
leukemia: From highly fatal to highly curable. Blood.
111:2505–2515. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Albanesi J, Noguera NI, Banella C,
Colangelo T, De Marinis E, Leone S, Palumbo O, Voso MT, Ascenzi P,
Nervi C, et al: Transcriptional and metabolic dissection of
ATRA-induced granulocytic differentiation in NB4 acute
promyelocytic leukemia cells. Cells. 9(2423)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Molinaro A, Zanta D, Moleti ML, Giona F,
Conter V, Rizzari C, Biondi A and Testi AM: Challenging management
of severe differentiation syndrome in pediatric acute promyelocytic
leukemia treated with ATRA/ATO. Mediterr J Hematol Infect Dis.
14(e2022027)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Montesinos P, Bergua JM, Vellenga E, Rayón
C, Parody R, de la Serna J, León A, Esteve J, Milone G, Debén G, et
al: Differentiation syndrome in patients with acute promyelocytic
leukemia treated with all-trans retinoic acid and anthracycline
chemotherapy: Characteristics, outcome, and prognostic factors.
Blood. 113:775–783. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jambrovics K, Uray IP, Keresztessy Z,
Keillor JW, Fésüs L and Balajthy Z: Transglutaminase 2 programs
differentiating acute promyelocytic leukemia cells in all-trans
retinoic acid treatment to inflammatory stage through NF-κB
activation. Haematologica. 104:505–515. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dubois C, Schlageter MH, de Gentile A,
Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean
Y, Degos L, et al: Modulation of IL-8, IL-1 beta, and G-CSF
secretion by all-trans retinoic acid in acute promyelocytic
leukemia. Leukemia. 8:1750–1757. 1994.PubMed/NCBI
|
|
8
|
Guo QW, Li F, Song L, Wang YP and Yang XM:
Effect of PADI4 on the expression of inflammatory cytokines during
NB4 cells differentiation. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
29:1065–1070. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
9
|
Nakashima K, Hagiwara T, Ishigami A,
Nagata S, Asaga H, Kuramoto M, Senshu T and Yamada M: Molecular
characterization of peptidylarginine deiminase in HL-60 cells
induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J
Biol Chem. 274:27786–27792. 1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nakashima K, Arai S, Suzuki A, Nariai Y,
Urano T, Nakayama M, Ohara O, Yamamura K, Yamamoto K and Miyazaki
T: PAD4 regulates proliferation of multipotent haematopoietic cells
by controlling c-myc expression. Nat Commun. 4(1836)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nakashima K, Hagiwara T and Yamada M:
Nuclear localization of peptidylarginine deiminase V and histone
deimination in granulocytes. J Biol Chem. 277:49562–49568.
2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Christophorou MA, Castelo-Branco G,
Halley-Stott RP, Oliveira CS, Loos R, Radzisheuskaya A, Mowen KA,
Bertone P, Silva JC, Zernicka-Goetz M, et al: Citrullination
regulates pluripotency and histone H1 binding to chromatin. Nature.
507:104–108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chang X and Han J: Expression of
peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol
Carcinog. 45:183–196. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Song G, Shi L, Guo Y, Yu L, Wang L, Zhang
X, Li L, Han Y, Ren X, Guo Q, et al: A novel PAD4/SOX4/PU.1
signaling pathway is involved in the committed differentiation of
acute promyelocytic leukemia cells into granulocytic cells.
Oncotarget. 7:3144–3157. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sanz MA, Fenaux P, Tallman MS, Estey EH,
Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ,
et al: Management of acute promyelocytic leukemia: Updated
recommendations from an expert panel of the european LeukemiaNet.
Blood. 133:1630–1643. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tang L, Chai W, Ye F, Yu Y, Cao L, Yang M,
Xie M and Yang L: HMGB1 promotes differentiation syndrome by
inducing hyperinflammation via MEK/ERK signaling in acute
promyelocytic leukemia cells. Oncotarget. 8:27314–27327.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fuss IJ, Kanof ME, Smith PD and Zola H:
Isolation of whole mononuclear cells from peripheral blood and cord
blood. Curr Protoc Immunol. 7:7.1.1–7.1.8, (Suppl 85).
2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang Y and Dai M: Expression of PADI4 in
patients with ankylosing spondylitis and its role in mediating the
effects of TNF-α on the proliferation and osteogenic
differentiation of human mesenchymal stem cells. Int J Mol Med.
36:565–570. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Harney SM, Meisel C, Sims AM, Woon PY,
Wordsworth BP and Brown MA: Genetic and genomic studies of PADI4 in
rheumatoid arthritis. Rheumatology (Oxford). 44:869–872.
2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Stahl M and Tallman MS: Differentiation
syndrome in acute promyelocytic leukaemia. Br J Haematol.
187:157–162. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mohammadzadeh Z, Omidkhoda A, Chahardouli
B, Hoseinzadeh G, Moghaddam KA, Mousavi SA and Rostami S: The
impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on
differentiation syndrome in acute promyelocytic leukemia. BMC
Cancer. 21(46)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chang X, Han J, Pang L, Zhao Y, Yang Y and
Shen Z: Increased PADI4 expression in blood and tissues of patients
with malignant tumors. BMC Cancer. 9(40)2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chang X and Fang K: PADI4 and
tumourigenesis. Cancer Cell Int. 10(7)2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yao H, Li P, Venters BJ, Zheng S, Thompson
PR, Pugh BF and Wang Y: Histone Arg modifications and p53 regulate
the expression of OKL38, a mediator of apoptosis. J Biol Chem.
283:20060–20068. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang X, Gamble MJ, Stadler S, Cherrington
BD, Causey CP, Thompson PR, Roberson MS, Kraus WL and Coonrod SA:
Genome-wide analysis reveals PADI4 cooperates with Elk-1 to
activate c-Fos expression in breast cancer cells. PLoS Genet.
7(e1002112)2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ham A, Rabadi M, Kim M, Brown KM, Ma Z,
D'Agati V and Lee HT: Peptidyl arginine deiminase-4 activation
exacerbates kidney ischemia-reperfusion injury. Am J Physiol Renal
Physiol. 307:F1052–F1062. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
He W, Zhou P, Chang Z, Liu B, Liu X, Wang
Y, Li Y and Alam HB: Inhibition of peptidylarginine deiminase
attenuates inflammation and improves survival in a rat model of
hemorrhagic shock. J Surg Res. 200:610–618. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Knight JS, Luo W, O'Dell AA, Yalavarthi S,
Zhao W, Subramanian V, Guo C, Grenn RC, Thompson PR, Eitzman DT, et
al: Peptidylarginine deiminase inhibition reduces vascular damage
and modulates innate immune responses in murine models of
atherosclerosis. Circ Res. 114:947–956. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Knight JS, Subramanian V, O'Dell AA,
Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR and Kaplan
MJ: Peptidylarginine deiminase inhibition disrupts NET formation
and protects against kidney, skin and vascular disease in
lupus-prone MRL/lpr mice. Ann Rheum Dis. 74:2199–2206.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Montesinos P and Sanz MA: The
differentiation syndrome in patients with acute promyelocytic
leukemia: Experience of the pethema group and review of the
literature. Mediterr J Hematol Infect Dis.
3(e2011059)2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Luesink M, Pennings JL, Wissink WM,
Linssen PC, Muus P, Pfundt R, de Witte TJ, van der Reijden BA and
Jansen JH: Chemokine induction by all-trans retinoic acid and
arsenic trioxide in acute promyelocytic leukemia: Triggering the
differentiation syndrome. Blood. 114:5512–5521. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ninomiya M, Kiyoi H, Ito M, Hirose Y, Ito
M and Naoe T: Retinoic acid syndrome in NOD/scid mice induced by
injecting an acute promyelocytic leukemia cell line. Leukemia.
18:442–448. 2004.PubMed/NCBI View Article : Google Scholar
|
